Orthopaedic Center for Musculoskeletal Research, Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University, Würzburg, Germany.
Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):765-83. doi: 10.1016/j.addr.2010.04.004. Epub 2010 Apr 14.
The last decade has witnessed the development of cell-based therapy as a major biomedical research area, including the treatment of musculoskeletal diseases. Both differentiated and undifferentiated stem cells have been used as starting cell sources. In particular, the use of multipotent adult mesenchymal stem cells holds great promise for future therapeutic strategies. In addition to the cell type used, the cell delivery system is also of critical importance in cell-based therapy. Cell delivery may be achieved by direct cell injection or by grafting engineered constructs derived by cell seeding into natural or synthetic biomaterial scaffolds. While direct injection is the most direct and convenient means of cell delivery, the latter approach is capable of producing three-dimensional engineered tissues with mechanical properties compatible with those of various musculoskeletal tissues. This review will focus on the functional approach of using biomaterial scaffold materials as cell carriers for musculoskeletal applications, as well as the use of cell-based gene therapy for tissue engineering and regeneration.
过去十年见证了细胞疗法的发展,成为一个主要的生物医学研究领域,包括肌肉骨骼疾病的治疗。分化细胞和未分化细胞都被用作起始细胞来源。特别是,多能成体间充质干细胞的应用为未来的治疗策略提供了巨大的希望。除了所用的细胞类型外,细胞输送系统在细胞疗法中也至关重要。细胞输送可以通过直接细胞注射或通过将种子细胞接种到天然或合成生物材料支架中产生的工程化构建体来实现。虽然直接注射是最直接和方便的细胞输送方式,但后一种方法能够产生具有与各种肌肉骨骼组织相匹配的机械性能的三维工程组织。本综述将重点介绍使用生物材料支架材料作为细胞载体在肌肉骨骼应用中的功能方法,以及基于细胞的基因治疗在组织工程和再生中的应用。